Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESECT: 5-ALA Fluorescence-Guided Surgery vs Neuronavigation in Glioblastoma
NCT01811121Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2013
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in glioblastoma (GBM), sponsored by Hospices Civils de Lyon. Started Feb 2013; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01811121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811121.